Methods of assessing wolframin protein activity

Details Methods of assessing wolframin protein activity Methods of assessing wolframin protein activity

2006-05-02

2006-05-02

Rao, Manjunath (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

C435S212000, C435S004000, C435S069100, C435S252300, C435S320100, C536S023200, C536S023500

Reexamination Certificate

active

07037695

ABSTRACT:
The present invention relates to a method of assaying modulators of the interaction between Wolframin protein and its identified cellular binding partner.

REFERENCES:
patent: 5776689 (1998-07-01), Karin et al.
patent: 6127521 (2000-10-01), Berlin et al.
patent: 6248527 (2001-06-01), Chen et al.
patent: 6251676 (2001-06-01), Shioda et al.
patent: 6316223 (2001-11-01), Payan et al.
patent: WO 00/23784 (2000-04-01), None
Bartel, P., et al., “Elimination of false positives that arise in using the two-hybrid system,” Biotechniques 14(6):920-4 [1993].
Che, F-Y, et al., “Identification of peptides from brain and pituitary ofCpefat/ Cpefatmice,” PNAS 98(17):9971-76 [2001].
Chien, C-T, et al., “The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest,” PNAS 88(21):9578-82 [1991].
Cool, D.R., et al., “Carboxypeptidase E is a regulated secretory pathway sorting receptor: Genetic obliteration leads to endocrine disorders inCpefatmice,” Cell 88:73-83 [1997].
Dang, C.V. et al., “Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization,” Molecular and Cellular Biology 11(2):954-62 [1991].
Dove, S.L. et al., “Conversion of the ω subunit ofEscherichia coliRNA polymerase into a transcriptional activator or an activation target,” Genes & Development 12:745-54 [1998].
Dove, S.L. et al., “Activation of prokaryotic transcription through arbitrary protein-protein contacts,” Nature 386(6625):627-30 [1997].
Duman, R.S. et al., “Neural Plasticity to stress and antidepressant treatment,” Society of Biological Psychiatry 46:1181-91 [1999].
Durfee, T., et al., “The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit,” Genes & Development 7:555-69 [1993].
Fields, S. et al., “A novel genetic system to detect protein-protein interactions,” Nature 340(6230):245-46 [1989].
Fricker, L.D., “Activation and membrane binding of carboxypeptidase E,” J. Cellular Biochemistry 38:279-289 [1988].
Fricker, L.D. et al., “Purification and characterization of enkephalin convertase, an ankephalin-synthesizing carboxypeptidase,” J. Biological Chemistry 258(18):10,950-955 [1983].
Fricker, L.D. et al., “Methods for studying carboxypeptidase E,” Methods in Neurosciences 23:237-50 [1995].
Fricker, L.D.,“Peptide Biosynthesis and Processing: Chapter 8—Peptide processing exopeptidases: Amino-and Carboxypeptidases involved with peptide biosynthesis,” pp. 199-230 CRC Press, Boca Raton, FL) [1991].
Gabreels, B.A.Th.F, et al., “The vasopressin precursor is not processed in the hypothalamus of Wolfram Syndrome patients with diabetes insipidus: Evidence for the involvement of PC2 and 7B2,” J. Clinical Endocrinology & Metabolism 83(11):4026-33 [1998].
Hannon, G.J. et al., “Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins,” Genes & Development 7:2378-91 [1993].
Hardy, C.F.J. et al., “A RAP1-interacting protein involved in transcriptional silencing and telomere length regulation,” Genes & Development 6:801-14 [1992].
Harper, J.W. et al., “The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases,” Cell 75:805-16 [1993].
Inoue, H. et al., “A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome),” Nature Genetics 20:143-48 [1998].
Kadonaga, J.T. et al., “Affinity purification of sequence-specific DNA binding proteins,” PNAS 83(16):5889-93 [1986].
Kohler, G. et al., “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature 256(5517):495-97 [1975].
LeDouarin, B., et al., “A new version of the two-hybrid assay for detection of protein-protein interactions,” Nucleic Acids Research 23(5):876-78 [1995].
Luban, J. et al., “Human Immunodeficiency Virus type 1 Gag protein binds to cyclophilins A and B,” Cell 73(6):1067-78 [1993].
Manser, E. et al., “Human carboxypeptidase E,” Biochem. J. 267(2):517-25 [1990].
Owen, M.J., “Psychiatric disorders in Wolfram syndrome heterozygotes,” Molecular Psychiatry 3:12-13 [1998].
Parodi, L.A., et al., “A consensus procedure for predicting the location of α-Helical transmembrane segments in proteins,” 10(5):527-35 [1994].
Silver, S.C. et al., “Techniques for cloning cDNAs encoding interactive transcriptional regulatory proteins,” Molecular Biology Reports 17(3):155-65 [1993].
Song, L., et al., “The pro region is not required for the expression or intracellular routeing of carboxypeptidase E,” Biochem. J. 323:265-71 [1997].
Sonnhammer, E.L.L. et al., “A hidden Markov model for predicting transmembrane helices in protein sequences,” Proc. Int. Conf. Intell. Syst. Mol. Biol. 6:175-82 [1998].
Strom, T.M. et al., “Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein,” Human Molecular Genetics 7(13):2021-28 [1998].
Swift, R.G., et al., “Psychiatric disorders in 36 families with Wolfram syndrome,” Am. J. Psychiatry 148(6):775-79 [1991].
Swift, R.G. et al., “Predisposition of Wolfram syndrome heterozygotes to psychiatric illness,” Molecular Psychiatry 3:86-91 [1998 ].
Torres, R. et al., “Mutation screening of the Wolfram syndrome gene in psychiatric patients,” Molecular Psychiatry 6:39-43 [2001].
Varlamov, O. et al., “Induced and spontaneous mutations at Ser202of carboxypeptidase E,” J. Biological Chemistry 271(24):13,981-986 [1996].
Vojtek, A.B. et al., “Mammalian Ras interacts directly with the serine/threonine kinase Raf,” Cell:74(1):205-14 [1993].
Yang, X. et al., “A protein kinase substrate identified by the two-hybrid system,” Science 257(5070):680-82 [1992].
Young, K. et al., “Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen,” Nature Biotechnology 16:946-50 [1998].
Zervos, A.S. et al., “Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites,” Cell 72(2):223-32 [1993 ].
Awata Takuya et. al., “Missense variations of the gene responsible for Wolfram syndrome (WFS1/wolframin) in Japanese: Possible contribution of the Arg456His mutation to type 1 diabetes as a nonautoimmune genetic basis.”Biochemical and Biophysical Research Communications., vol. 268, No. 2, Feb. 16, 2000, pp. 612-616.
Varlamov Oleg et. al., “The C-terminal region of carboxypeptidase E involved in membrane binding is distinct from the region involved with intracellular routing.”Journal of Biological Chemistry., vol. 271, No. 11, 1996, pp. 6077-6083.

Affiliated with

Also associated with

Rating

Methods of assessing wolframin protein activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of assessing wolframin protein activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of assessing wolframin protein activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3545701